News
TRUMF
14.38
NaN%
--
Morgan Stanley Keeps Their Hold Rating on Terumo (TRUMF)
TipRanks · 3h ago
Weekly Report: what happened at TRUMF last week (0928-1002)?
Weekly Report · 4h ago
Weekly Report: what happened at TRUMF last week (0921-0925)?
Weekly Report · 09/28 09:44
TransMedics Offers An Attractive Entry Point, With Upside Potential Outweighing Risks
Seeking Alpha · 09/26 11:56
Weekly Report: what happened at TRUMF last week (0914-0918)?
Weekly Report · 09/21 09:44
Daiwa Sticks to Its Buy Rating for Terumo (TRUMF)
TipRanks · 09/17 11:35
Weekly Report: what happened at TRUMF last week (0907-0911)?
Weekly Report · 09/14 09:46
Weekly Report: what happened at TRUMF last week (0831-0904)?
Weekly Report · 09/07 09:43
Terumo (TRUMF) Receives a Buy from SMBC Nikko
TipRanks · 09/04 10:06
Weekly Report: what happened at TRUMF last week (0824-0828)?
Weekly Report · 08/31 09:47
Weekly Report: what happened at TRUMF last week (0817-0821)?
Weekly Report · 08/24 09:47
Terumo to Liquidate Singapore Asset Management Subsidiary After Capital Reduction
TipRanks · 08/21 06:54
UBS Keeps Their Buy Rating on Terumo (TRUMF)
TipRanks · 08/17 11:40
Weekly Report: what happened at TRUMF last week (0810-0814)?
Weekly Report · 08/17 09:48
Terumo (TRUMF) Receives a Hold from Goldman Sachs
TipRanks · 08/10 10:28
Macquarie Sticks to Their Buy Rating for Terumo (TRUMF)
TipRanks · 08/10 10:27
Weekly Report: what happened at TRUMF last week (0803-0807)?
Weekly Report · 08/10 09:45
Terumo GAAP EPS of ¥47.73, revenue of ¥311.81B; updates FY 2207 outlook
Seeking Alpha · 08/07 08:04
UBS Keeps Their Buy Rating on Terumo (TRUMF)
TipRanks · 08/04 13:06
Terumo Completes Treasury Share Disposal for Restricted Stock Compensation
TipRanks · 08/04 09:52
More
Webull provides a variety of real-time TRUMF stock news. You can receive the latest news about Terumo through multiple platforms. This information may help you make smarter investment decisions.
About TRUMF
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.